Article

Is it possible to predict hypothyroidism after thyroid lobectomy through thyrotropin, thyroglobulin, anti-thyroglobulin, and anti-microsomal antibody?

Department of Surgery, Chonnam National University Medical School, Gwangju, Korea.
Journal of the Korean Surgical Society 12/2011; 81(6):380-6. DOI: 10.4174/jkss.2011.81.6.380
Source: PubMed

ABSTRACT We investigated the incidence and risk factors of hypothyroidism after thyroid lobectomy, and evaluated the possibility to predict hypothyroidism preoperatively with serologic markers, such as thyrotropin (TSH), thyroglobulin (TG), anti-thyroglobulin (ATA), and anti-microsomal antibody (AMA).
We enrolled 123 consecutive patients who underwent thyroid lobectomy due to benign conditions between May 2004 and April 2008. Only preoperative euthyroid patients were included. Patients were divided into two groups by postoperative thyroid function outcomes, into hypothyroid (n = 97) and euthyroid groups (n = 26), and analyzed specially for the preoperative levels of TSH, TG, ATA, and AMA.
Twenty-six (21.1%) patients developed hypothyroidism following thyroid lobectomy within 35.7 months of follow-up. The proportion of post-lobectomy hypothyroidism was high in patients with high-normal preoperative TSH level, and the cut-off value was 2.0 mIU/L, with 67% sensitivity and 75% specificity. The quantitative titer of preoperative TG, ATA, and AMA was not significant, but the outcome of categorical analysis of two or more positivities on these three markers was significantly higher in hypothyroid patients than in euthyroid patients (28.6% vs. 3.9%, P = 0.024). The combined positivity of preoperative TSH and two or more positivities of TG, ATA, and AMA possess 100% positive predictive value and 81% negative predictive value.
The incidence of hypothyroidism following thyroid lobectomy was 21.1%. High-normal preoperative TSH and two or more positivities for TG, ATA, and AMA are good pre-operative predictive markers. Such high-risk patients need close TSH monitoring before the onset of clinical hypothyroidism.

0 Followers
 · 
135 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To evaluate whether preoperative thyroiditis idenified by ultrasound (US) could help predict the need for post-thyroid-lobectomy thyroid hormone replacement (THR).Methods: Data from patients who underwent thyroid lobectomy in 2006-2011, were not taking THR preoperatively, and had ≥1 month follow-up were reviewed retrospectively. THR was prescribed for relatively elevated thyroid-stimulating hormone (TSH) and hypothyroid symptoms. The Kaplan-Meier method estimated the percentage of patients who required THR at 6, 12, 18, and 24 months postoperatively, and Cox proportional hazards regression models evaluated prognostic factors for requiring post-thyroid lobectomy THR.Results: During follow-up, 45 of 98 patients required THR. Median follow-up among patients not requiring THR was 11.6 (range: 1.2-51.3) months. Six months after thyroid lobectomy, 22% were taking THR (95% confidence interval [CI]: 15-32%); the percentage increased to 46% at 12 months (95% CI: 36-57%) and 55% at 18 months (95% CI: 43-67%). On univariate analysis, significant prognostic factors for postoperative THR included preoperative TSH level >2.5 μIU/ml (hazard ratio [HR]: 2.8, 95% CI: 1.4-5.5, P=0.004) and pathology-identified thyroiditis (HR: 2.4, 95% CI: 1.3-4.3, P=0.005). Patients with both preoperative TSH >2.5 μIU/ml and US-identified thyroiditis had a 5.8-fold increased risk of requiring postoperative THR (95% CI: 2.4-13.9, P<0.0001).Conclusions: Preoperative TSH >2.5 μIU/ml significantly increases the risk of requiring THR after thyroid lobectomy. Thyroiditis can add to that prediction and guide preoperative patient counseling and surgical decision-making. US-identified thyroiditis should be reported and post-thyroid lobectomy patients followed long-term (≥18 months).
    Endocrine Practice 09/2013; 19(6):1-22. DOI:10.4158/EP12334.OR · 2.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Organochlorine (OC) pesticides are endocrine disruptors altering the thyroid hormonal system. The aim of this study is to investigate the relationship between exposure to OC pesticides and thyroid status in adults from a rural area in Rio de Janeiro, Brazil, heavily contaminated with OC pesticides. A cross-sectional study was carried out in 303 men and 305 women >14 years old. Concentrations of 19 OC pesticides and levels of free thyroxine (T4), total triiodothyronine (T3), thyroid-stimulating hormone (TSH), anti-thyroperoxidase (TPOAb) and anti-thyroglobulin (TgAg) antibodies were analyzed in serum samples. Associations between OC pesticides concentrations and values of biochemical thyroid parameters were determined using multivariate regression models stratified by gender. Prevalence of subclinical hyperthyroidism and the presence of TPOAb antibodies were higher than those described for euthyroid populations elsewhere. After adjusting for confounders, total T3 levels were associated with lower concentrations of endosulphan 2 in men and with higher alpha-chlordane, p,p'-dichlorodiphenyltrichloroethane (DDT), endosulphan 2, and methoxychlor in women. Levels of free T4 showed inverse association with beta-hexachlorocyclohexane (HCH) and p,p'-DDT in men, and were positively associated with hexachlorobenzene (HCB), heptachlor, o,p'-DDT, and p,p'-DDT in women. TSH levels were associated with higher beta-HCH in men. A positive association was observed between exposure methoxychlor in males and presence of TPOAb, but no association with TPOAb was found in women. These results suggest that OC pesticides can affect the thyroid system through gender-specific mechanisms that may differ among compounds. Further detailed investigations and health monitoring should be warranted for this population.
    Environmental Research 10/2013; DOI:10.1016/j.envres.2013.09.001 · 3.95 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: ABSTRACT Purpose: No previous study regarding the correlation between post-operative thyroid function and underlying thyroid histopathology has been published. This study assessed the relationship between postoperative thyroid function after lobectomy and multiple factors in papillary thyroid microcarcinoma (PTMC) patients. Materials and methods: From January 2010 to December 2010, 338 patients who had undergone thyroid lobectomy for PTMC were enrolled. Patients with pre-operative hyperthyroidism or those with hypothyroidism but no pre-operative serological data were excluded, leaving a cohort of 285 patients. The relationships between post-operative thyroid function (based on successful cessation of thyroxine replacement therapy) and multiple factors (patient age and sex, serological data, the Pre-operative anteroposterior diameter of the thyroid gland, underlying histopathology of the thyroid gland, and number of attempts to stop thyroxine replacement therapy) were analyzed. Results: Out of 285 patients, 157 attempted to stop thyroxine replacement therapy once or twice after lobectomy; 91 successfully stopped thyroxine replacement therapy during the study period. The final histopathologic diagnoses after surgery included Hashimoto's thyroiditis (n = 5), non-Hashimoto type of lymphocytic thyroiditis (n = 17), and normal thyroid parenchyma (n = 135). Pre-operative thyroid-stimulating hormone (TSH) levels differed significantly between patients with postoperative hypothyroidism and those with postoperative euthyroidism (univariate logistic regression analysis, p = 0.0028; multivariate logistic regression analysis, p = 0.0029). No statistically significant differences were found for any other factors. Conclusions: The study results demonstrated that the Pre-operative TSH level was the only predictor for the development of post-operative hypothyroidism after thyroid lobectomy in PTMC patients.
    Endocrine Research 08/2014; 40(1):1-5. DOI:10.3109/07435800.2014.933975 · 1.41 Impact Factor

Full-text (3 Sources)

Download
61 Downloads
Available from
Jun 2, 2014